# BUDA (Buda Juice, Inc.) - SEC EDGAR Financial Statements

> Buda Juice, Inc. reported $16.12M in revenue and net income of $2.40M for the trailing twelve months ended September 30, 2026 (up 64.4% year over year), with a 39.6% gross margin and a 16.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/BUDA
- Markdown: https://convexityos.com/fundamentals/BUDA.md
- SEC CIK: 0002079720
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002079720&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $16.12M | +64.4% YoY |
| Operating Income | TTM | $2.67M | 16.5% margin |
| Net Income | TTM | $2.40M | 14.9% net margin |
| Diluted EPS | TTM | $0.19 | Split-adjusted |
| Free Cash Flow | TTM | $2.90M | 18.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $19.28M | Total debt: $1.33M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Revenue** | $12.61M | $11.27M |
| Cost of Revenue | $6.98M | $6.07M |
| **Gross Profit** | $5.63M | $5.21M |
| Selling, General & Admin | $1.67M | $1.30M |
| Total Operating Expenses | $2.18M | $1.80M |
| **Operating Income** | $3.45M | $3.41M |
| **EBITDA** | $3.69M | $3.69M |
| Income Tax Expense | $0 | -- |
| **Net Income** | $3.53M | $3.57M |
| Basic EPS | $0.28 | $0.28 |
| **Diluted EPS** | $0.20 | $0.20 |
| Basic Shares Outstanding | 10.0K | 10.0K |
| Diluted Shares Outstanding | 14.0K | 14.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.21M | $4.51M | $3.51M | $2.90M | $3.17M | $3.57M | $2.98M |
| Cost of Revenue | $3.08M | $2.86M | $2.12M | $1.68M | $1.76M | $1.90M | $1.64M |
| **Gross Profit** | $2.12M | $1.65M | $1.39M | $1.22M | $1.41M | $1.67M | $1.34M |
| Selling, General & Admin | $925K | $1.05M | $663K | $488K | $398K | $378K | $407K |
| Total Operating Expenses | $1.13M | $1.21M | $793K | $584K | $538K | $523K | $535K |
| **Operating Income** | $996K | $444K | $593K | $632K | $870K | $1.14M | $803K |
| **EBITDA** | $1.06M | $507K | $650K | $653K | $932K | $1.21M | $890K |
| Income Before Tax | $1.14M | $599K | $747K | -- | $891K | $1.18M | $816K |
| Income Tax Expense | $274K | $129K | $359K | -$28K | $10K | $9.0K | $9.0K |
| **Net Income** | $866K | $470K | $388K | $675K | $881K | $1.17M | $807K |
| Basic EPS | $0.07 | $0.04 | $0.03 | -- | -- | -- | -- |
| **Diluted EPS** | $0.07 | $0.04 | $0.03 | -- | -- | -- | -- |
| Basic Shares Outstanding | 12.6M | 12.6M | 12.3K | -- | -- | -- | -- |
| Diluted Shares Outstanding | 12.6M | 12.9M | 12.4K | -- | -- | -- | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $1.84M | $1.89M |
| **Cash & Short-Term Investments** | $1.84M | $1.89M |
| Accounts Receivable, Net | $386K | $395K |
| Inventory | $348K | $374K |
| **Total Current Assets** | $3.22M | $2.70M |
| Property, Plant & Equipment, Net | $976K | $969K |
| **Total Non-Current Assets** | $1.75M | $1.03M |
| **Total Assets** | $4.97M | $3.73M |
| Accounts Payable | $289K | $449K |
| Other Current Liabilities | $161K | $58K |
| **Total Current Liabilities** | $585K | $575K |
| Long-Term Debt | $647K | -- |
| **Total Non-Current Liabilities** | $647K | $0 |
| **Total Liabilities** | $1.23M | $575K |
| **Total Debt (incl. Leases)** | $1.43M | $68K |
| Common Stock | $2.55M | $5.50M |
| Retained Earnings | $1.18M | -$2.35M |
| **Total Stockholders' Equity** | $3.74M | $3.16M |
| Total Equity | $3.74M | $3.16M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $19.28M | -- | $19.83M | $1.84M | $1.89M |
| **Cash & Short-Term Investments** | $19.28M | -- | $19.83M | $1.84M | $1.89M |
| Accounts Receivable, Net | -- | -- | $494K | $386K | $395K |
| Inventory | $721K | $613K | $445K | $348K | $374K |
| **Total Current Assets** | $22.60M | $21.56M | $20.98M | $3.22M | $2.70M |
| Property, Plant & Equipment, Net | $1.73M | $1.54M | $1.14M | $976K | $969K |
| **Total Non-Current Assets** | $2.40M | $2.25M | $1.88M | $1.75M | $1.03M |
| **Total Assets** | $25.00M | $23.81M | $22.86M | $4.97M | $3.73M |
| Accounts Payable | -- | -- | $623K | $289K | $449K |
| Other Current Liabilities | $205K | -- | $279K | $161K | $58K |
| **Total Current Liabilities** | $1.46M | $1.42M | $1.04M | $585K | $575K |
| Long-Term Debt | $652K | $755K | $792K | $647K | -- |
| **Total Non-Current Liabilities** | $652K | $755K | $792K | $647K | $0 |
| **Total Liabilities** | $2.11M | $2.17M | $1.83M | $1.23M | $575K |
| **Total Debt (incl. Leases)** | $1.33M | $1.47M | $1.54M | $1.43M | $68K |
| Common Stock | $13K | $13K | $13K | $2.55M | $5.50M |
| Retained Earnings | $2.91M | $2.04M | $1.57M | $1.18M | -$2.35M |
| **Total Stockholders' Equity** | $22.89M | $21.64M | $21.03M | $3.74M | $3.16M |
| Total Equity | $22.89M | $21.64M | $21.03M | $3.74M | $3.16M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | $3.53M | $3.57M |
| Depreciation & Amortization | $239K | $274K |
| Change in Receivables | $8.0K | -$28K |
| Change in Inventory | $26K | $34K |
| **Operating Cash Flow** | $3.15M | $3.97M |
| Capital Expenditure | -$246K | -$684K |
| **Free Cash Flow** | $2.90M | $3.29M |
| **Investing Cash Flow** | -$246K | -$684K |
| **Financing Cash Flow** | -$2.95M | -$2.83M |
| **Net Change in Cash** | -$47K | $461K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $866K | $470K | $388K | $675K | $881K | $1.17M | $807K |
| Depreciation & Amortization | $67K | $63K | $57K | $21K | $62K | $69K | $87K |
| Stock-Based Compensation | -- | $213K | -- | -- | -- | -- | -- |
| Change in Receivables | -$412K | -$1.36M | -$108K | $11K | $102K | $38K | -$143K |
| Change in Inventory | -$108K | -$68K | -$97K | $64K | $71K | -$164K | $55K |
| **Operating Cash Flow** | $710K | -$365K | $1.30M | $483K | $834K | $929K | $904K |
| Capital Expenditure | -- | -- | -$218K | $64K | -- | -- | -$139K |
| **Free Cash Flow** | -- | -- | $1.09M | $547K | -- | -- | $765K |
| **Investing Cash Flow** | -$252K | -$570K | -$218K | $64K | -$40K | -$131K | -$139K |
| **Financing Cash Flow** | $0 | -$74K | $16.90M | -$769K | -$434K | -$310K | -$1.44M |
| **Net Change in Cash** | $458K | -$1.01M | $17.99M | -$222K | $360K | $488K | -$673K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Gross Margin** | 44.6% | 46.2% |
| **Operating Margin** | 27.4% | 30.3% |
| **Net Profit Margin** | 28.0% | 31.7% |
| Return on Equity (ROE) | 94.5% | 113.2% |
| Return on Assets (ROA) | 71.1% | 95.8% |
| Current Ratio | 5.50x | 4.69x |
| Quick Ratio | 4.91x | 4.04x |
| Debt to Equity | 0.38x | 0.02x |
| **Revenue Growth (YoY)** | +11.8% | -- |
| Gross Profit Growth (YoY) | +8.1% | -- |
| Operating Income Growth (YoY) | +1.1% | -- |
| **Net Income Growth (YoY)** | -1.1% | -- |
| EPS Growth (YoY) | 0.0% | -- |
| Operating Cash Flow Growth (YoY) | -20.7% | -- |
| Free Cash Flow Growth (YoY) | -11.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 39.6% | 40.2% | 43.2% | 44.6% | -- | -- | -- |
| **Operating Margin** | 16.5% | 18.0% | 24.7% | 27.4% | -- | -- | -- |
| **Net Profit Margin** | 14.9% | 17.1% | 23.7% | 28.0% | -- | -- | -- |
| Return on Equity (ROE) | 10.5% | 11.2% | 14.8% | 94.5% | -- | -- | -- |
| Return on Assets (ROA) | 9.6% | 10.1% | 13.6% | 71.1% | -- | -- | -- |
| Current Ratio | 15.52x | 15.21x | 20.16x | 5.50x | -- | -- | -- |
| Quick Ratio | 15.03x | 14.77x | 19.73x | 4.91x | -- | -- | -- |
| Debt to Equity | 0.06x | 0.07x | 0.07x | 0.38x | -- | -- | -- |
| **Revenue Growth (YoY)** | +64.4% | +26.4% | +17.7% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +50.9% | -1.0% | +3.6% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | +14.5% | -61.2% | -26.2% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -1.7% | -59.8% | -51.9% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -14.9% | -139.3% | +44.4% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | +42.1% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
